Atlas Trials

A Single Center, Prospective Clinical Trial of Intravenous Ertapenem in the Treatment of Hurley Stage II or III Hidradenitis Suppurativa

Clinical trial NCT05255575 · WITHDRAWN

Trial details

NCT number
NCT05255575
Sponsor
Henry Ford Health System
Status
WITHDRAWN
Study type
OBSERVATIONAL
Hidradenitis Suppurativa
Start date
2018-03-01
Primary completion
2019-07-07
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.